JPH10234844A - Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same - Google Patents

Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same

Info

Publication number
JPH10234844A
JPH10234844A JP9058398A JP5839897A JPH10234844A JP H10234844 A JPH10234844 A JP H10234844A JP 9058398 A JP9058398 A JP 9058398A JP 5839897 A JP5839897 A JP 5839897A JP H10234844 A JPH10234844 A JP H10234844A
Authority
JP
Japan
Prior art keywords
copolymer
cartilage tissue
cartilage
lactic acid
regenerating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9058398A
Other languages
Japanese (ja)
Inventor
Shinichiro Morita
真一郎 森田
Masaki Honda
雅規 本田
Minoru Ueda
実 上田
Hiroharu Kimata
弘治 木全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gunze Ltd
Original Assignee
Gunze Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunze Ltd filed Critical Gunze Ltd
Priority to JP9058398A priority Critical patent/JPH10234844A/en
Publication of JPH10234844A publication Critical patent/JPH10234844A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To enable decomposition and absorption of a cartilaginous tissue after the elapsing of a specified period with easier formation of the tissue by forming a sponge- like molded product having a cell holding structure out of a polycondensation body of any of lactic acid, glycolic acid and caprolactone or a copolymer thereof to make it adapted to the proliferation of cartilaginous cells. SOLUTION: Material herein used is a polycondensation body of any of lactic acid, glycolic acid and caprolactone or copolymer thereof, the example, a copolymer of lactic acid and glycolic acid. This copolymer is properly treated and molded as desired in a porous form to make a sponge-like molded product for surgery. The pore diameter of the molded product is not limited if the structure thereof can hold cells, preferably cartilaginous cells. But, normally, the pore diameter is about 1mm or less, preferably about 5-100μm. The density of the product is about 0.1-10g/cm<3> , preferably about 1-5g/cm<3> . This structure can improve breaking strength, breaking by elongation and elasticity thereby easily producing a mold according to the figure of a patient. This also enables regeneration of a cartilaginous tissue in a short time.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、乳酸、グリコール
酸もしくはカプロラクトンの重縮合体又はそれらの共重
合体からなる生体吸収性高分子をスポンジ状にしてなる
新規な成型物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel sponge-shaped bioabsorbable polymer comprising a polycondensate of lactic acid, glycolic acid or caprolactone or a copolymer thereof.

【0002】また本発明は軟骨組織再建法において、軟
骨組織を再生するための良好な足場となる新規基材及び
該基材を用いた軟骨組織再生法に関する。
[0002] The present invention also relates to a novel base material serving as a good scaffold for regenerating cartilage tissue in a cartilage tissue reconstruction method, and a cartilage tissue regeneration method using the base material.

【0003】なお、「軟骨組織再建法」とは手術、外傷
等によって喪失した軟骨組織を細胞培養法によって再構
成し、それを患者に移植することにより軟骨を再生する
方法である。
[0003] The "cartilage tissue reconstruction method" is a method of regenerating cartilage by reconstructing cartilage tissue lost by surgery, trauma, or the like by a cell culture method and transplanting it into a patient.

【0004】[0004]

【従来の技術】近年の細胞培養技術の進歩により、数々
の動物細胞の培養が可能となり、またそれらの細胞から
組織を再構築するという試みが行われつつある(細胞工
学、14(12) 1995)。このような試みにおいて最も重要
なことは播種する細胞が生体組織を再建するまでの足場
となるマトリックスの作製である。
2. Description of the Related Art Recent advances in cell culture technology have enabled the cultivation of many animal cells, and attempts are being made to reconstruct tissues from those cells (Cell Engineering, 14 (12) 1995). ). The most important thing in such an attempt is the preparation of a matrix that serves as a scaffold for the seeded cells to reconstruct the living tissue.

【0005】この分野において実用化面で最も進んでい
るのは皮膚である。丸口らはコラーゲンを用いた発泡体
を作製し、これに線維芽細胞を播種、更にこの上部に表
皮角化細胞を播種することによって表皮、真皮の構造を
有する培養人工皮膚を作製した(Plast. Reconstr. Sur
g. 93: 537, 1994)。コラ−ゲンは生体適合性に優れ、
また組織が再生された後には分解吸収されるため、この
ような目的には非常に適している。
[0005] Skin is the most advanced in practical application in this field. Maruguchi et al. Prepared a foam using collagen, inoculated with fibroblasts, and then inoculated epidermal keratinocytes on the foam to produce a cultured artificial skin having an epidermal and dermal structure (Plast . Reconstr. Sur
g. 93: 537, 1994). Collagen has excellent biocompatibility,
It is also very suitable for such purposes, as it is degraded and absorbed after tissue regeneration.

【0006】軟骨の再生においても組織再建の試みが行
われている。桟敷らは上記人工皮膚に使用したものと同
様のコラーゲンスポンジを足場として、これに軟骨細胞
を播種することによって、軟骨組織の再建に成功してい
る(Biomaterials 17 (1996)155-162)。またVaca
ntiらは生体吸収性高分子であるグリコール酸と乳酸
の共重合体からなる繊維を基材としてこれに軟骨細胞を
播種することによって軟骨組織を再生する試みを行って
いる(Plast. Reconstr. Surg. 88, 753, 1991)。
In cartilage regeneration, tissue reconstruction has been attempted. Have succeeded in the reconstruction of cartilage tissue by using a collagen sponge similar to that used for the artificial skin as a scaffold and seeding it with chondrocytes (Biomaterials 17 (1996) 155-162). Also Vaca
nti et al. have attempted to regenerate cartilage tissue by seeding chondrocytes on a fiber consisting of a copolymer of glycolic acid and lactic acid, which are bioabsorbable polymers (Plast. Reconstr. Surg. . 88, 753, 1991).

【0007】しかし、これらの方法ではいずれも基材の
物性面に問題があり、実用的な軟骨組織の再生は難し
い。すなわちコラーゲンスポンジを基材とする場合、コ
ラーゲンは細胞培養の基材として非常に優れたものでは
あるが、一方で非常に柔軟なものしか作製できないた
め、必要とする形状を作製することは困難である。すな
わち試験管内で必要な培養軟骨細胞が形成された後、生
体に移植する場合に、ある程度の強度がないと、生体内
で形を維持することはできない。また生体吸収性高分子
を用いる場合でも、繊維を用いてマトリックスの基材を
作る試みについても、自由に必要とする構造を有した基
材を作製することは困難である。
However, these methods have problems in the physical properties of the base material, and it is difficult to regenerate cartilage tissue for practical use. That is, when a collagen sponge is used as a base material, collagen is very excellent as a base material for cell culture, but on the other hand, only a very flexible one can be produced, so it is difficult to produce a required shape. is there. That is, after transplantation into a living body after the necessary cultured chondrocytes have been formed in a test tube, the shape cannot be maintained in the living body without a certain strength. Even in the case where a bioabsorbable polymer is used, it is difficult to freely produce a substrate having a required structure in an attempt to produce a matrix substrate using fibers.

【0008】従って理想的な軟骨細胞のマトリックスの
基材として容易に3次元の形状を自由に作ることのでき
る素材が必要とされる。たとえば耳介の形成を行う場合
にはマトリックスによって耳介の形状を形成した後、移
植することによって組織が再生できるものが理想とな
る。
Therefore, there is a need for a material capable of easily forming a three-dimensional shape freely as an ideal base material of a chondrocyte matrix. For example, when forming an auricle, it is ideal that the tissue can be regenerated by forming the shape of the auricle with a matrix and then implanting the same.

【0009】[0009]

【発明が解決しようとする課題】従って、本発明の目的
は、(1)軟骨細胞増殖のために最適な足場となり、
(2)適度な強度を有しており目的とする軟骨組織の形
状を容易に作成することができ、さらに(3)生体に移
植された後は所望の期間経過後、分解吸収される、とい
う性質を備えたスポンジ状成型物、好ましくは細胞播種
用基材、より具体的には軟骨組織再生用の基材を提供す
ることである。
Accordingly, an object of the present invention is to provide (1) an optimal scaffold for chondrocyte proliferation,
(2) It has an appropriate strength and can easily produce the desired shape of cartilage tissue. (3) It is said that after transplantation into a living body, it is decomposed and absorbed after a desired period of time. An object of the present invention is to provide a sponge-like molded product having properties, preferably a substrate for cell seeding, more specifically, a substrate for cartilage tissue regeneration.

【0010】また、本発明の他の目的は、生体内で短期
間に効率よく軟骨組織再生効果を奏する軟骨組織再生用
基材−軟骨細胞複合体を提供することである。
Another object of the present invention is to provide a cartilage tissue-regenerating substrate-chondrocyte complex which has a cartilage tissue regenerating effect in a short period of time and efficiently.

【0011】[0011]

【課題を解決するための手段】本発明者らは、上記諸目
的を解決すべく鋭意検討した結果、軟骨細胞の足場とし
て特定の生体吸収性高分子からなる多孔体を用いること
によって上記性質を兼ね備えた軟骨組織再生用基材を提
供することができることを知り、この知見に基づいて本
発明を完成するに至った。
Means for Solving the Problems The present inventors have conducted intensive studies in order to solve the above-mentioned objects, and as a result, have found that the above properties can be obtained by using a porous body made of a specific bioabsorbable polymer as a scaffold for chondrocytes. We have found that a cartilage tissue regeneration base material can be provided, and based on this knowledge, we have completed the present invention.

【0012】即ち、本発明の第一は、乳酸、グリコール
酸もしくはカプロラクトンのいずれかの重縮合体又はこ
れらの共重合体のいずれかからなり、細胞保持構造を有
することを特徴とするスポンジ状成型物である。
That is, a first aspect of the present invention is a sponge-like molding comprising a polycondensate of any of lactic acid, glycolic acid and caprolactone or a copolymer thereof, and having a cell holding structure. Things.

【0013】また本発明の第二は、乳酸、グリコール酸
もしくはカプロラクトンのいずれかの重縮合体又はこれ
らの共重合体のいずれかから構成される多孔体からなる
ことを特徴とする軟骨組織再生用基材である。なお、多
孔体としては、より好ましくはスポンジ状のものが挙げ
られる。また、当該多孔体は細胞接着促進物質でコート
されていてもよい。
[0013] A second aspect of the present invention is a cartilage tissue regeneration method comprising a polycondensate of any of lactic acid, glycolic acid and caprolactone, or a porous material composed of any of these copolymers. It is a substrate. In addition, as a porous body, a sponge-like thing is more preferable. The porous body may be coated with a cell adhesion promoting substance.

【0014】さらに本発明の第三は、上記軟骨組織再生
用基材及び軟骨細胞を含有する軟骨組織再生用複合体で
ある。
[0014] A third aspect of the present invention is a cartilage tissue regeneration complex containing the above-mentioned cartilage tissue regeneration base material and chondrocytes.

【0015】さらにまた本発明の第四は、前記軟骨組織
再生用基材に、軟骨細胞を播種し、移植することによっ
て軟骨を再生することを特徴とする軟骨組織再生法であ
る。
Further, a fourth aspect of the present invention is a method for regenerating cartilage tissue, wherein cartilage is regenerated by sowing chondrocytes on the substrate for regenerating cartilage tissue and transplanting the same.

【0016】[0016]

【発明の実施の形態】本発明の成型物は、合成の生体吸
収性高分子である乳酸の重縮合体(ポリ乳酸)、グリコ
ール酸の重縮合体(ポリグリコール酸)、カプロラクト
ンの重縮合体(ポリカプロラクトン)、乳酸とグリコー
ル酸との共重合体、グリコール酸とカプロラクトンとの
共重合体、乳酸とカプロラクトンとの共重合体又は乳
酸、グリコール酸及びカプロラクトンの共重合体のいず
れかを、適当な処理をすることによって多孔質状とし、
所望の形態に成型してなる外科用成型物である。
BEST MODE FOR CARRYING OUT THE INVENTION The molded product of the present invention is a polycondensate of lactic acid (polylactic acid), a polycondensate of glycolic acid (polyglycolic acid), and a polycondensate of caprolactone, which are synthetic bioabsorbable polymers. (Polycaprolactone), a copolymer of lactic acid and glycolic acid, a copolymer of glycolic acid and caprolactone, a copolymer of lactic acid and caprolactone, or a copolymer of lactic acid, glycolic acid and caprolactone, To make it porous by
It is a surgical molded product formed into a desired form.

【0017】ここで多孔質状とは、内部に多数の小さな
空隙(孔:ポア)を有する形状のものを意味し、具体的
にはスポンジ状、蜂の巣状又はそれらと同等なものが挙
げられるが、好ましくはスポンジ状である。
Here, the porous shape means a shape having a large number of small voids (holes: pores) therein, and specific examples thereof include a sponge shape, a honeycomb shape, and the like. , Preferably in the form of a sponge.

【0018】その孔径は、細胞、好ましくは軟骨細胞を
保持できる構造であれば特に制限はされないが、通常1
mm以下、好ましくは5〜100μmであり、密度は
0.1〜10g/cm3、好ましくは1〜5g/cm3
ある。
The pore size is not particularly limited as long as it can hold cells, preferably chondrocytes.
mm or less, preferably 5 to 100 [mu] m, density of 0.1 to 10 g / cm 3, preferably from 1 to 5 g / cm 3.

【0019】用いられる重合体の平均分子量、混合組
成、重合比、重合法等は特に制限されないが、調製され
た成型物に細胞を播種した場合、該細胞が成型物表面ま
たは内部に付着・保持され、成型物とともに培養された
場合に細胞が増殖できる性質を有していることが好まし
い。より好ましくは多孔質状に成形してなる成型物が、
細胞を播種し軟骨を形成したときに軟骨としての適当な
強度、弾性を有し、かつ軟骨が再生された後は分解吸収
されるように適宜選択される。
The average molecular weight, mixed composition, polymerization ratio, polymerization method and the like of the polymer used are not particularly limited. However, when cells are seeded on the prepared molded product, the cells adhere and retain on the surface or inside of the molded product. It is preferable that the cells have the property of allowing cells to proliferate when cultured with a molded article. More preferably, a molded product obtained by molding into a porous shape,
When the cells are seeded to form cartilage, they are appropriately selected so as to have appropriate strength and elasticity as cartilage, and to be decomposed and absorbed after cartilage is regenerated.

【0020】例えば、本発明の成型物の一態様として
は、上記重縮合体または共重合体からなる成型物であっ
て、その引張破断強度が0.1kgf/cm2以上で成
形後の粘度平均分子量が1〜50万の範囲であり、しか
も体内に埋植された場合には、1年以内好ましくは6ヶ
月以内に分解吸収されるものが挙げられる。
For example, one embodiment of the molded article of the present invention is a molded article comprising the above-mentioned polycondensate or copolymer, having a tensile strength at break of 0.1 kgf / cm 2 or more and an average viscosity after molding. When the molecular weight is in the range of 100,000 to 500,000 and is implanted in the body, it can be decomposed and absorbed within one year, preferably within six months.

【0021】上記特性を有するスポンジ状成型物の製造
方法は、特に制限されないが、一態様として例示するな
ら、粘度平均分子量として1〜50万、好ましくは5〜
30万を有する重縮合体又は共重合体の溶液を所望の型
枠に入れ、凍結後、真空凍結乾燥することによって所望
の形態のスポンジ状成型物を得ることができる。あるい
は作製したスポンジを適当な形にカットすることによっ
て成形することも可能である。
The method for producing a sponge-like molded product having the above-mentioned properties is not particularly limited, but as an example, the viscosity average molecular weight is 100,000 to 500,000, preferably 50,000 to 500,000.
A polycondensate or copolymer solution having 300,000 is placed in a desired mold, frozen, and then freeze-dried under vacuum to obtain a sponge-like molded product in a desired form. Alternatively, the formed sponge can be formed by cutting the sponge into an appropriate shape.

【0022】より具体的に説明すると、例えば、本発明
で用いられる乳酸重縮合体(ポリ乳酸)は、光学活性を
有するL体又はD体の乳酸から常法(C. E. Lowe. U.
S. P.2,668, 162号)に従って乳酸の環状二量体である
ラクチドを合成した後、そのラクチドを開環重合するこ
とによって得られるものである。重合は、一般に減圧下
または不活性ガス雰囲気下において重合温度100〜2
50℃で、スズ系、亜鉛系、アルミニウム系等の化合物
を触媒として行うことができる。
More specifically, for example, the lactic acid polycondensate (polylactic acid) used in the present invention can be prepared from an optically active L-form or D-form lactic acid by a conventional method (CE Lowe.
SP2668, 162), a lactide that is a cyclic dimer of lactic acid is synthesized, and then the lactide is subjected to ring-opening polymerization. The polymerization is generally carried out at a polymerization temperature of 100 to 2 under reduced pressure or an inert gas atmosphere.
The reaction can be carried out at 50 ° C. using a tin-based, zinc-based, aluminum-based compound or the like as a catalyst.

【0023】また、本発明においては上記乳酸重縮合体
に代えて、グリコール酸の重縮合体(ポリグリコール
酸)又はカプロラクトンの重縮合体(ポリカプロラクト
ン)も用いられる。これらの製造方法も、常法に従って
行うことができる。
In the present invention, a polycondensate of glycolic acid (polyglycolic acid) or a polycondensate of caprolactone (polycaprolactone) is used in place of the lactic acid polycondensate. These production methods can also be performed according to a conventional method.

【0024】更に、本発明において、上記重縮合体に代
えて、乳酸、グリコール酸又はカプロラクトンのいずれ
かから構成される共重合体を用いることができる。
Further, in the present invention, a copolymer composed of lactic acid, glycolic acid or caprolactone can be used instead of the above polycondensate.

【0025】かかる共重合体は、ランダム共重合体又は
ブロック共重合体のいずれであってもよい。これらのブ
ロック共重合体は、種々の長さの一連の鎖セグメントか
らなり、各セグメントはモノマーのホモポリマーからな
るか、あるいは二種以上の共重合体を含むランダム共重
合体からなるものであってもよい。
The copolymer may be either a random copolymer or a block copolymer. These block copolymers consist of a series of chain segments of various lengths, each segment consisting of a homopolymer of monomers or a random copolymer comprising two or more copolymers. You may.

【0026】上記特性を有するスポンジ成型物を構成す
るものであれば、これら共重合体の配合比は特に制限さ
れず、また常法に従って製造することができる。
The mixing ratio of these copolymers is not particularly limited as long as they constitute a sponge molded product having the above characteristics, and the copolymer can be produced according to a conventional method.

【0027】上記本発明のスポンジ状成型物は、その用
途を限定するものではなく、その特性を生かしていかな
る用途にも使用することができる。好ましくは、細胞の
足場としての用途または細胞播種材料としての用途が例
示される。
The sponge-like molded article of the present invention is not limited in its use, but can be used for any purpose by taking advantage of its properties. Preferably, use as a cell scaffold or use as a cell seeding material is exemplified.

【0028】また当該成型物の成型の態様も特に制限さ
れず、目的に応じて適宜選択することができる。
The form of the molded product is not particularly limited, and can be appropriately selected according to the purpose.

【0029】本発明に係る軟骨組織再生用基材は、上記
成型物の一態様として挙げられるものである。この場合
の成型の態様は、例えば耳や鼻等、所望の再建対象物の
形態を考慮して、それらの形に適合するよう加工され
る。
The cartilage tissue regeneration base material according to the present invention is one of the above-mentioned molded products. In this case, the form of the molding is processed so as to conform to the shape of the object to be reconstructed, for example, the ear or the nose, in consideration of the desired form.

【0030】「軟骨組織再生用基材」とは、in vitroで
軟骨細胞を播種した場合に、該細胞が好適に増殖する足
場となり、また該細胞を含んだ状態で生体内に埋め込ん
だ場合には、その中の軟骨細胞が速やかに分化・再生
し、それとともに基材自身は分解吸収されるものをい
う。本発明の「軟骨組織再生用基材」は、とりわけ軟骨
様の適度な強度、弾性を有しているため扱い易く、また
軟骨細胞を含有させ生体内に移植した場合には軟骨組織
の再生が数週間という短期間で行われることを特徴とす
るものである。
The “substrate for regenerating cartilage tissue” is a scaffold on which cartilage cells can be suitably proliferated when seeded in vitro, and when cartilage cells are embedded in a living body while containing the cells. Means that the chondrocytes therein rapidly differentiate and regenerate, and the substrate itself is decomposed and absorbed. The `` substrate for regenerating cartilage tissue '' of the present invention is particularly easy to handle because it has moderate cartilage-like strength and elasticity, and also contains cartilage cells and, when transplanted into a living body, regenerates cartilage tissue. It is characterized by being performed in a short period of several weeks.

【0031】かかる効果を奏する本発明の軟骨組織再生
用基材は、前述の成型物の中でも生体への埋植後、形の
崩れない強度と、一定の柔軟性、さらには6ヶ月程度で
分解吸収されるという特性を有するものが好適に挙げら
れる。
The base material for cartilage tissue regeneration of the present invention exhibiting the above-mentioned effects is one of the above-mentioned molded products, which has the strength not to lose its shape after implantation into a living body, has a certain flexibility, and decomposes in about 6 months. Those having the property of being absorbed are preferred.

【0032】なお、本発明の成形物及び軟骨組織再生用
基材は、更にその多孔質表面が細胞接着促進物質によっ
て被覆されていてもよい。
The molded product and the substrate for cartilage tissue regeneration of the present invention may further have a porous surface coated with a cell adhesion promoting substance.

【0033】細胞接着促進物質とは、細胞の接着を促進
する性質を有するものであればよく、特に制限はない
が、具体的にはコラーゲン、ゼラチン等が例示される。
The cell adhesion promoting substance is not particularly limited as long as it has a property of promoting cell adhesion, and specific examples thereof include collagen, gelatin and the like.

【0034】被覆方法は特に制限されず、常法に従って
行うことができるが、簡便には後述の実施例2で示すよ
うに、多孔質状基材を調製後、細胞接着促進物質に浸漬
し、その後再度凍結乾燥する方法が例示される。
The coating method is not particularly limited and can be carried out according to a conventional method. For convenience, as shown in Example 2 below, after preparing a porous substrate, it is immersed in a cell adhesion promoting substance. Then, a method of freeze-drying again is exemplified.

【0035】また、本発明は上記軟骨組織再生用基材を
用いた軟骨細胞複合体を提供する。
The present invention also provides a chondrocyte complex using the above-mentioned substrate for cartilage tissue regeneration.

【0036】かかる軟骨組織再生用基材−軟骨細胞複合
体は、上記軟骨組織再生用基材からなるマトリックスに
軟骨細胞が含まれてなるものであり、軟骨組織再生用移
植片もしくは軟骨組織再生用治療材として有用である。
Such a cartilage tissue regeneration substrate-chondrocyte complex comprises a matrix composed of the above-mentioned cartilage tissue regeneration substrate and containing chondrocytes, and is used as a cartilage tissue regeneration graft or cartilage tissue regeneration. Useful as a therapeutic material.

【0037】調製方法は特に制限されないが、例えば前
述の軟膏組織再生用基材を使用目的に応じて適当な大き
さ・形状に調製した後、例えば、これに軟骨細胞分散液
を注入して、5%CO2/37℃インキュベーターにて
培養後24時間程度培養する方法等が挙げられる。
The preparation method is not particularly limited. For example, after preparing the above-mentioned ointment tissue regenerating base material into an appropriate size and shape according to the purpose of use, for example, a chondrocyte dispersion liquid is poured into the base material. at 5% CO 2/37 ℃ incubator and a method of culturing about 24 hours of culture.

【0038】用いられる軟骨細胞としては、好ましくは
当該複合体が適用される被験者と免疫原性が近似もしく
は同一のものが挙げられる。軟骨細胞は、常法に従って
調整できるが、コラゲナーゼ等の酵素処理によって調整
する方法が一般的である。
The chondrocytes used preferably include those having immunogenicity close to or the same as the subject to which the complex is applied. The chondrocytes can be prepared according to a conventional method, but generally prepared by treatment with an enzyme such as collagenase.

【0039】複合体を調整する際の軟骨細胞分散液の細
胞濃度は、使用目的、使用部位、疾病の程度などによっ
て適宜変更できるが、好ましくは軟骨組織再生用基材1
cm3あたり、含まれる細胞濃度が1×102個以上、好
ましくは1×103〜1×108個、さらに好ましくは1
×104〜1×107個となるように調整することが望ま
しい。
The cell concentration of the chondrocyte dispersion when preparing the complex can be appropriately changed depending on the purpose of use, the site of use, the degree of disease, and the like.
The cell concentration per cm 3 is 1 × 10 2 or more, preferably 1 × 10 3 to 1 × 10 8 , more preferably 1 × 10 3 to 1 × 10 8.
It is desirable to adjust so as to be × 10 4 to 1 × 10 7 .

【0040】本発明の複合体を、例えば耳の軟骨の再建
に用いる場合は、耳の適用部位に適合するよう成型・加
工した軟骨組織再生用基材に軟骨細胞分散液を注入し
て、一定期間培養して調製した本発明複合体を、該耳の
適用部位に埋め込むことにより行われる。
When the composite of the present invention is used for, for example, reconstruction of cartilage of an ear, a chondrocyte dispersion is injected into a substrate for cartilage tissue regeneration molded and processed so as to be adapted to a site to which the ear is applied. This is carried out by implanting the complex of the present invention prepared by culturing for a period of time in the site of application to the ear.

【0041】なお、本発明の成型物及び軟骨組織再生用
基材は、合成の生体吸収性高分子を用いているため、コ
ラーゲンなどの天然高分子とは異なり、安定した均一の
品質のものを提供することができ、また簡便に滅菌処理
等ができるため細菌の増殖や汚染を防止することがで
き、さらに分子量、重合度、混合組成を自由に調整でき
るため、所望の強度や分解速度を有する基材の調製が簡
便にできるという点でも有用である。
Since the molded article and the cartilage tissue regeneration substrate of the present invention use a synthetic bioabsorbable polymer, they have a stable and uniform quality unlike natural polymers such as collagen. It can be provided, and can be easily sterilized to prevent the growth and contamination of bacteria.Furthermore, the molecular weight, polymerization degree, and mixed composition can be freely adjusted, so that it has desired strength and decomposition rate. It is also useful in that the base material can be easily prepared.

【0042】また、本発明は上記軟骨組織再生用基材
に、軟骨細胞を播種することによって軟骨を再生するこ
とを特徴とする軟骨組織再生法である。
Further, the present invention is a method for regenerating cartilage tissue, which comprises regenerating cartilage by disseminating chondrocytes on the above-mentioned substrate for regenerating cartilage tissue.

【0043】軟骨細胞の播種方法、用いられる軟骨細胞
等は、前記の通りである。また、軟骨の再生は、播種さ
れた軟骨細胞を含む軟骨組織再生用基材(軟骨組織再生
用複合体)を生体内に埋め込む方法、又は生体外で培養
することにより行われる。
The method of seeding chondrocytes, the chondrocytes used and the like are as described above. In addition, the regeneration of cartilage is performed by a method of embedding a cartilage tissue regeneration base material (complex for cartilage tissue regeneration) containing seeded chondrocytes in a living body, or by culturing in vitro.

【0044】生体外で培養し、軟骨組織が再生されたも
のについては、適宜生体内に埋め込むことにより軟骨組
織の再建に使用される。この生体外で培養することによ
る軟骨組織再生法は、予め必要とする軟骨組織を再生
し、それをストックしておけるといった利点がある。
The cartilage tissue that has been cultured in vitro and the cartilage tissue has been regenerated is used for reconstruction of the cartilage tissue by appropriately implanting it in the living body. The method of cartilage tissue regeneration by culturing in vitro has the advantage that cartilage tissue required in advance can be regenerated and stocked.

【0045】[0045]

【実施例】以下、本発明の内容を以下の実施例及び実験
例を用いて具体的に説明するが、本発明はこれらに何ら
限定されるものではない。
EXAMPLES Hereinafter, the present invention will be described in detail with reference to the following examples and experimental examples, but the present invention is not limited to these examples.

【0046】実施例1 乳酸−カプロラクトン共重合
体の発泡体の調製 乳酸/カプロラクトン共重合体(P(LA−CL))
(50:50)2gを100mlジオキサンに入れ、4
0℃で撹拌溶解した。これをガラス製型枠に流延し、−
30℃冷凍庫に入れ、1時間凍結させた後40℃、24
時間真空凍結乾燥した。このようにして作製したスポン
ジ(基材1)は柔軟な性状を有していた。
Example 1 Preparation of Foam of Lactic Acid / Caprolactone Copolymer Lactic acid / caprolactone copolymer (P (LA-CL))
(50:50) 2 g in 100 ml dioxane, 4
The mixture was stirred and dissolved at 0 ° C. This was cast on a glass mold,
Place in a 30 ° C freezer, freeze for 1 hour, then
Vacuum freeze-dried for hours. The sponge (base material 1) produced in this manner had a flexible property.

【0047】これを走査電子顕微鏡で観察すると無数の
孔が表面に露出した多孔体構造を呈しており、織布や不
織布等の構造とは明らかに相違していた(図1参照)。
When this was observed with a scanning electron microscope, it was found to have a porous structure in which a myriad of holes were exposed on the surface, which was clearly different from structures such as woven cloth and nonwoven cloth (see FIG. 1).

【0048】実施例2 ゼラチンコート乳酸−カプロ
ラクトン共重合体の発泡体の調製 医療用ゼラチン2gを100mlの蒸留水に入れ、30
℃で撹拌溶解した。これを実施例1で調製した基材1に
十分浸潤させ、−135℃にて1時間凍結後、真空凍結
乾燥した。このようにして作製したものを走査電子顕微
鏡にて観察したところ基材1と同様に多孔体を呈してい
た(図2参照)。また基材1に比べると発泡スチロ−ル
状の硬さを呈し、カッターにて成形可能であった。
Example 2 Preparation of Foam of Gelatin-Coated Lactic Acid-Caprolactone Copolymer 2 g of medical gelatin was placed in 100 ml of distilled water,
The mixture was stirred and dissolved at ℃. This was sufficiently infiltrated into the substrate 1 prepared in Example 1, frozen at -135 ° C for 1 hour, and then freeze-dried in vacuum. Observation of the thus-prepared product with a scanning electron microscope revealed a porous body as in the case of the substrate 1 (see FIG. 2). Further, as compared with the base material 1, it exhibited a styrofoam-like hardness and could be molded by a cutter.

【0049】実験例1 上記実施例1及び実施例2で調製した各共重合体スポン
ジについて、乾燥状態及び湿潤状態での引張破断強度、
引張破断伸びを測定した。測定は、20mm幅の試料を
用いて引張速度500mm/分の条件で、オートグラフ
にて行った。尚、比較試料として、コラーゲンスポンジ
を用いて同様な実験を行った(比較例)。
Experimental Example 1 For each of the copolymer sponges prepared in Examples 1 and 2, the tensile strength at break in dry and wet states
The tensile elongation at break was measured. The measurement was performed by an autograph using a sample having a width of 20 mm at a tensile speed of 500 mm / min. The same experiment was performed using a collagen sponge as a comparative sample (Comparative Example).

【0050】結果を表1に示す。Table 1 shows the results.

【0051】[0051]

【表1】 [Table 1]

【0052】これから、本発明の共重合体スポンジは、
コラーゲンスポンジよりも破断強度が格段向上し、破断
伸びもよいことが分かる。また、細胞接着促進物質であ
るゼラチンで被覆することにより、引張破断強度が向上
することが判明した。
From this, the copolymer sponge of the present invention is
It can be seen that the breaking strength is significantly improved and the breaking elongation is better than that of the collagen sponge. In addition, it was found that the tensile breaking strength was improved by coating with gelatin, which is a cell adhesion promoting substance.

【0053】実施例3 (1)軟骨細胞採取 Lewis系4週令雄性ラット肋軟骨を無菌的に採取
し、付着する軟組織を可及的に除去し取り出した軟骨を
細片化した。次いで、酵素液〔第一液:0.1%EDTA
(ナカライテスク社製)/PBS(−)(ローマン工業
社製)、第二液:0.25%トリプシン−EDTA(ギブコ
社製)/PBS(−)(ローマン工業社製)、第三液:
0.1%コラゲナーゼ(和光純薬社製)/PBS(+)
(ギブコ社製)〕をそれぞれ入れた試験管中にこの軟骨
組織を入れ、37℃でそれぞれ15分間、1時間、3時
間処理して軟骨組織を分解した。採取した軟骨分散液を
培地中〔D−MEM(Dulbeco's Modified Eagle Mediu
m:ギブコ社製)+10%FCS(FETAL BOVINE SERUM)
+ペニシリン+ストレプトマイシン)に入れ、コンフル
エント状態になるまで、約2週間、37℃、5%CO2
下で培養した。得られた培養液を0.25%トリプシン/P
BS(−)で5分間処理して、1000rpm、10分
間遠心分離し、軟骨細胞を回収した。
Example 3 (1) Collection of chondrocytes [0053] The costal cartilage of a 4-week-old Lewis male rat was aseptically collected, the attached soft tissue was removed as much as possible, and the removed cartilage was fragmented. Next, an enzyme solution [first solution: 0.1% EDTA
(Nacalai Tesque) / PBS (-) (Roman Industries), second liquid: 0.25% trypsin-EDTA (Gibco) / PBS (-) (Roman Industries), third liquid:
0.1% collagenase (manufactured by Wako Pure Chemical Industries) / PBS (+)
(Manufactured by Gibco)] was placed in a test tube, and treated at 37 ° C. for 15 minutes, 1 hour and 3 hours, respectively, to decompose the cartilage tissue. The collected cartilage dispersion was placed in a medium [D-MEM (Dulbeco's Modified Eagle Mediu
m: Gibco) + 10% FCS (FETAL BOVINE SERUM)
+ Penicillin + streptomycin) at 37 ° C., 5% CO 2 for about 2 weeks until confluent.
Cultured underneath. The obtained culture was subjected to 0.25% trypsin / P
The cells were treated with BS (-) for 5 minutes, centrifuged at 1000 rpm for 10 minutes, and the chondrocytes were collected.

【0054】(2)軟骨細胞播種 上記方法にて採取した軟骨細胞を実施例1及び2で調製
した基材1及ぴ基材2(1cm×1cm)それぞれに5×1
6Cells/50μlの濃度で注射器にて注入し、3時
間、37℃、5%CO2下で培養後、培地を2ml追加
してさらに24時間培養して、軟骨組織再生用基材−軟
骨細胞複合体を調製した。
(2) Seeding of chondrocytes The chondrocytes collected by the above method were placed on each of the base materials 1 and 2 (1 cm × 1 cm) prepared in Examples 1 and 2 by 5 × 1.
0 6 was injected at a syringe at a concentration of Cells / 50 [mu] l, 3 h, 37 ℃, 5% CO 2 After culturing under, and further cultured for 24 hours the medium was added 2 ml, cartilage tissue regeneration substrate - Cartilage A cell complex was prepared.

【0055】実験例2 移植実験 実施例3で調製した軟骨組織再生用基材−軟骨細胞複合
体を、ヌードマウス(KSN−nuSlc:日本エスエ
ルシー)の背部皮下に移植した。
Experimental Example 2 Transplantation Experiment The cartilage tissue regeneration substrate-chondrocyte complex prepared in Example 3 was subcutaneously transplanted into the back of a nude mouse (KSN-nuSlc: Japan SLC).

【0056】移植4週後に移植片を回収し、ヘマトキシ
リン・エオジン染色を行い組織を観察した。また軟骨プ
ロテオグリカンについてはAlcian−Blue染
色、Azan染色及びAggrecan免疫抗体染色を
行い、光学顕微鏡で観察した。移植4週後の組織切片を
観察した結果、Azan染色及びAggrecan免疫
抗体染色において複合体内部に軟骨塊の形成を示す高い
染色域が認められた(各々図3及び4参照)。
Four weeks after transplantation, the transplant was collected and stained with hematoxylin and eosin to observe the tissue. In addition, cartilage proteoglycan was subjected to Alcian-Blue staining, Azan staining, and Aggrecan immunoantibody staining, and observed with an optical microscope. As a result of observing the tissue section 4 weeks after the transplantation, a high staining area showing the formation of a cartilage mass inside the complex was observed by Azan staining and Aggrecan immunoantibody staining (see FIGS. 3 and 4, respectively).

【0057】以上のことから、本発明の多孔質状の軟骨
組織再生用基材は、適度な強度と弾性を有するため、3
次元の形状を自由に作れて患部の形状に応じた成型加工
が容易にでき、さらにはそれに軟骨細胞を付着させて生
体内に埋め込むことによって、わずか数週間という短期
間で軟骨組織の再生が可能であることが判明した。
From the above, the porous cartilage tissue regeneration base material of the present invention has moderate strength and elasticity,
The three-dimensional shape can be freely created and the molding process can be easily performed according to the shape of the diseased part.Furthermore, cartilage tissue can be regenerated in just a few weeks by attaching chondrocytes to it and implanting it in the living body Turned out to be.

【図面の簡単な説明】[Brief description of the drawings]

【図1】 実施例1で調製した、乳酸/カプロラクトン
共重合体のスポンジ状多孔体の構造を走査電子顕微鏡で
観察した、図面に代わる電子顕微鏡写真である。
FIG. 1 is an electron micrograph instead of a drawing, in which the structure of a spongy porous body of a lactic acid / caprolactone copolymer prepared in Example 1 was observed with a scanning electron microscope.

【図2】 実施例2で調製した、ゼラチン被覆−乳酸/
カプロラクトン共重合体のスポンジ状多孔体の構造を走
査電子顕微鏡で観察した、図面に代わる電子顕微鏡写真
である。
FIG. 2: Gelatin-coated lactic acid /
3 is an electron micrograph instead of a drawing, in which the structure of a sponge-like porous body of a caprolactone copolymer is observed with a scanning electron microscope.

【図3】 本発明の基材−軟骨細胞複合体を移植後、4
週間めの軟骨塊形成状態をAzan染色で示す図面に代
わる写真である。
FIG. 3. After transplantation of the substrate-chondrocyte complex of the present invention, 4
It is a photograph substituted for the drawing which shows the cartilage mass formation state of the week by Azan staining.

【図4】 本発明の基材−軟骨細胞複合体を移植後、4
週間めの軟骨塊形成状態をAggrecan免疫抗体染
色で示す図面に代わる写真である。
FIG. 4. After transplantation of the substrate-chondrocyte complex of the present invention, 4
It is a photograph substituted for the drawing which shows the cartilage mass formation state of the week by Aggrecan immunological antibody staining.

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】乳酸、グリコール酸もしくはカプロラクト
ンのいずれかの重縮合体又はこれらの共重合体のいずれ
かからなり、細胞保持構造を有することを特徴とするス
ポンジ状成型物。
1. A sponge-like molded product comprising a polycondensate of any of lactic acid, glycolic acid or caprolactone or a copolymer thereof, and having a cell holding structure.
【請求項2】乳酸、グリコール酸もしくはカプロラクト
ンのいずれかの重縮合体又はこれらの共重合体のいずれ
かから構成される多孔体からなることを特徴とする軟骨
組織再生用基材。
2. A cartilage tissue regeneration base material comprising a porous body composed of a polycondensate of any of lactic acid, glycolic acid and caprolactone or a copolymer thereof.
【請求項3】多孔体がスポンジ状である請求項2記載の
軟骨組織再生用基材。
3. The substrate for cartilage tissue regeneration according to claim 2, wherein the porous body is sponge-like.
【請求項4】多孔体が細胞接着促進物質でコートされて
なるものである請求項2または3記載の軟骨組織再生用
基材。
4. The substrate for cartilage tissue regeneration according to claim 2, wherein the porous body is coated with a cell adhesion promoting substance.
【請求項5】請求項2乃至4のいずれかに記載の軟骨組
織再生用基材及び軟骨細胞を含む軟骨組織再生用複合
体。
5. A cartilage tissue regeneration complex comprising the cartilage tissue regeneration substrate according to claim 2 and a chondrocyte.
【請求項6】請求項2乃至4のいずれかに記載の軟骨組
織再生用基材に、軟骨細胞を播種することによって軟骨
を再生することを特徴とする軟骨組織再生法。
6. A method for regenerating cartilage by disseminating cartilage by seeding a chondrocyte on the substrate for regenerating cartilage tissue according to claim 2.
JP9058398A 1997-02-25 1997-02-25 Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same Pending JPH10234844A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9058398A JPH10234844A (en) 1997-02-25 1997-02-25 Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9058398A JPH10234844A (en) 1997-02-25 1997-02-25 Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same

Publications (1)

Publication Number Publication Date
JPH10234844A true JPH10234844A (en) 1998-09-08

Family

ID=13083258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9058398A Pending JPH10234844A (en) 1997-02-25 1997-02-25 Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same

Country Status (1)

Country Link
JP (1) JPH10234844A (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017572A1 (en) * 1999-09-09 2001-03-15 Gunze Limited Materials for culturing cardiovascular tissues and method of tissute regeneration
JP2002345455A (en) * 2001-05-24 2002-12-03 Seikagaku Kogyo Co Ltd Base material for culturing cartilage and agent for repairing cartilage
JP2002541925A (en) * 1999-04-16 2002-12-10 ラトガーズ,ザ ステイト ユニバーシティ Porous polymer scaffolds for tissue engineering
JP2003126238A (en) * 2001-10-22 2003-05-07 Gunze Ltd Base material for regenerating bone and osteochondro- bone
WO2003039614A1 (en) * 2001-11-06 2003-05-15 Shin-Ichi Kanemaru Base material for regenerating air sinus and regeneration method
JP2004136096A (en) * 2002-10-18 2004-05-13 Ethicon Inc Biocompatible scaffold with tissue fragment
JP2004194944A (en) * 2002-12-19 2004-07-15 Gunze Ltd Substrate for cartilage cultivation and its manufacturing method
EP1649872A1 (en) 2004-10-25 2006-04-26 GC Corporation Sheet for guiding regeneration of mesenchymal tissue and production method thereof
WO2006100935A1 (en) * 2005-03-18 2006-09-28 Jms Co., Ltd. Process for producing porous object and porous object obtained by the same
WO2007063820A1 (en) 2005-12-02 2007-06-07 Sunstar Suisse Sa Biocompatible material having biocompatible non-woven nano- or micro-fiber fabric produced by electrospinning method, and method for production of the material
WO2007111205A1 (en) 2006-03-20 2007-10-04 Jms. Co., Ltd. Porous bioabsorbable material and method of producing the same
EP2106811A2 (en) 2008-03-31 2009-10-07 GC Corporation Scaffold for tissue engineering and production method thereof
JP2009226148A (en) * 2008-03-25 2009-10-08 Gc Corp Production method of cell-technological block-like support
JP2009240766A (en) * 2008-03-10 2009-10-22 Gc Corp Bone tissue regeneration sheet and production method thereof
JP2010057942A (en) * 2001-07-19 2010-03-18 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7875296B2 (en) 2003-11-26 2011-01-25 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US8016867B2 (en) 1999-07-23 2011-09-13 Depuy Mitek, Inc. Graft fixation device and method
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US8293046B2 (en) 2007-03-30 2012-10-23 Jms Co., Ltd. Process for production of porous body and uses thereof
US8372433B2 (en) 2007-01-18 2013-02-12 Gunze Limited Substrate for culture of cardiovascular tissue
US8691259B2 (en) 2000-12-21 2014-04-08 Depuy Mitek, Llc Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US8895045B2 (en) 2003-03-07 2014-11-25 Depuy Mitek, Llc Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
JP2015057964A (en) * 2013-09-18 2015-03-30 株式会社ジーシー Support for tissue engineering
WO2018123814A1 (en) * 2016-12-28 2018-07-05 株式会社高研 High-strength collagen sponge
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002541925A (en) * 1999-04-16 2002-12-10 ラトガーズ,ザ ステイト ユニバーシティ Porous polymer scaffolds for tissue engineering
US8016867B2 (en) 1999-07-23 2011-09-13 Depuy Mitek, Inc. Graft fixation device and method
US8748142B2 (en) 1999-09-09 2014-06-10 Gunze Limited Culture of cardiovascular cells on a matrix and method for regenerating cardiovascular tissue
WO2001017572A1 (en) * 1999-09-09 2001-03-15 Gunze Limited Materials for culturing cardiovascular tissues and method of tissute regeneration
US8691259B2 (en) 2000-12-21 2014-04-08 Depuy Mitek, Llc Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
JP2002345455A (en) * 2001-05-24 2002-12-03 Seikagaku Kogyo Co Ltd Base material for culturing cartilage and agent for repairing cartilage
JP2010057942A (en) * 2001-07-19 2010-03-18 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
JP2003126238A (en) * 2001-10-22 2003-05-07 Gunze Ltd Base material for regenerating bone and osteochondro- bone
US7378088B2 (en) 2001-11-06 2008-05-27 shin-ichi Kanemaru Base material for regenerating an air sinus and regeneration method thereof
WO2003039614A1 (en) * 2001-11-06 2003-05-15 Shin-Ichi Kanemaru Base material for regenerating air sinus and regeneration method
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
JP2010119867A (en) * 2002-10-18 2010-06-03 Ethicon Inc Biocompatible support scaffold with tissue fragment
US10603408B2 (en) 2002-10-18 2020-03-31 DePuy Synthes Products, Inc. Biocompatible scaffolds with tissue fragments
US9511171B2 (en) 2002-10-18 2016-12-06 Depuy Mitek, Llc Biocompatible scaffolds with tissue fragments
JP2004136096A (en) * 2002-10-18 2004-05-13 Ethicon Inc Biocompatible scaffold with tissue fragment
JP2004194944A (en) * 2002-12-19 2004-07-15 Gunze Ltd Substrate for cartilage cultivation and its manufacturing method
JP4646487B2 (en) * 2002-12-19 2011-03-09 グンゼ株式会社 Cartilage culture substrate and production method thereof
US8895045B2 (en) 2003-03-07 2014-11-25 Depuy Mitek, Llc Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US9211362B2 (en) 2003-06-30 2015-12-15 Depuy Mitek, Llc Scaffold for connective tissue repair
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US7875296B2 (en) 2003-11-26 2011-01-25 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
EP1649872A1 (en) 2004-10-25 2006-04-26 GC Corporation Sheet for guiding regeneration of mesenchymal tissue and production method thereof
WO2006100935A1 (en) * 2005-03-18 2006-09-28 Jms Co., Ltd. Process for producing porous object and porous object obtained by the same
KR100847285B1 (en) 2005-03-18 2008-07-21 가부시끼가이샤 제이엠에스 Process for producing porous object and porous object obtained by the same
WO2007063820A1 (en) 2005-12-02 2007-06-07 Sunstar Suisse Sa Biocompatible material having biocompatible non-woven nano- or micro-fiber fabric produced by electrospinning method, and method for production of the material
WO2007111205A1 (en) 2006-03-20 2007-10-04 Jms. Co., Ltd. Porous bioabsorbable material and method of producing the same
US8372433B2 (en) 2007-01-18 2013-02-12 Gunze Limited Substrate for culture of cardiovascular tissue
US8293046B2 (en) 2007-03-30 2012-10-23 Jms Co., Ltd. Process for production of porous body and uses thereof
JP2009240766A (en) * 2008-03-10 2009-10-22 Gc Corp Bone tissue regeneration sheet and production method thereof
JP2009226148A (en) * 2008-03-25 2009-10-08 Gc Corp Production method of cell-technological block-like support
EP2106811A2 (en) 2008-03-31 2009-10-07 GC Corporation Scaffold for tissue engineering and production method thereof
JP2015057964A (en) * 2013-09-18 2015-03-30 株式会社ジーシー Support for tissue engineering
WO2018123814A1 (en) * 2016-12-28 2018-07-05 株式会社高研 High-strength collagen sponge

Similar Documents

Publication Publication Date Title
JPH10234844A (en) Base material for regenerating cartilaginous tissue and regenerating method of cartilaginous tissue using the same
Freed et al. Biodegradable polymer scaffolds for tissue engineering
Jawad et al. Myocardial tissue engineering.
US7674408B2 (en) Channeled biomedical foams an method for producing same
JP3493199B2 (en) Implantable prosthesis, kit and device for manufacturing the same
KR101027630B1 (en) Preparation method of porous scaffold by hyaluronic acid - collagen natural polymer for cartilage resuscitation
Vacanti et al. Tissue engineered growth of new cartilage in the shape of a human ear using synthetic polymers seeded with chondrocytes
US20030012805A1 (en) Implant for cartilage tissue regeneration
US20050214344A1 (en) Tissue engineered biomimetic hair follicle graft
JP5478885B2 (en) Biocompatible and biodegradable porous matrix particularly useful for tissue reconstruction
US20060147486A1 (en) Biodegradable dual porous scaffold wrapped with semi-permeable membrane and tissue cell culture using thereof
Guan et al. Elastase-sensitive elastomeric scaffolds with variable anisotropy for soft tissue engineering
JP2004501700A (en) Biocompatible polymer having three-dimensional structure using communicating cells, method for preparing the same, and application in medicine and surgery
WO2001017572A1 (en) Materials for culturing cardiovascular tissues and method of tissute regeneration
CN102618492B (en) Cartilage stent material for in-vitro directed induction of stem cells and preparation method thereof
JP3616344B2 (en) Chondrocyte culture method and cartilage tissue regeneration substrate
JP4344112B2 (en) Biological tissue-like structure, bone marrow stem cell culture method and culture kit
JP2001204807A (en) Base material for tissue culture, and biomedical material made of same
Vacanti The impact of biomaterials research on tissue engineering
KR100427557B1 (en) Bone collagen scaffold
Thomas et al. Tissue Engineering Systems
JP4373658B2 (en) Artificial skin with improved contractility
JP4464056B2 (en) Hair growth promoting composite material
Pietro et al. The influence of triethylcitrate on the biological properties of poly (L-lactic-co-glycolic acid) membranes
Wang et al. Three-dimensional culture of human periodontal ligament cells on highly porous polyglycolic acid scaffolds in vitro

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040630

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040827

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050727